Deficiencies of GM-CSF and interferon γ link inflammation and cancer

Journal of Experimental Medicine

Volumn 197, Issue 9, 2003, Pages 1213-1219

  Enzler, Thomas ^a   Gillessen, Silke ^a   Manis, John P ^b   Ferguson, David ^b   Fleming, James ^b   Alt, Frederick W ^b   Mihm, Martin ^c   Dranoff, Glenn ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cancer; GM CSF; IFN ; Inflammation; SLE

Indexed keywords

ANTIBIOTIC AGENT; FAS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; HEMATOLOGIC MALIGNANCY; HOMEOSTASIS; INFECTION; INFLAMMATION; LYMPHOMA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROPHYLAXIS; SOLID TUMOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMATION; INTERFERON TYPE II; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; NEOPLASMS;

EID: 0038558189     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021258     Document Type: Article

References (30)

1. Cordon-Cardo, C., and C. Prives. 1999. At the crossroads of inflammation and tumorigenesis. J. Exp. Med. 190:1367-1370.
2. Mackay, I.R., and N.R. Rose. 2001. Autoimmunity and lymphoma: tribulations of B cells. Nat. Immunol. 2:793-795.
3. Kuper, H., H.O. Adami, and D. Trichopoulos. 2000. Infections as a major preventable cause of human cancer. J. Intern. Med. 248:171-183.
4. Ekbom, A., C. Helmick, M. Zack, and H.O. Adami. 1990. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med. 323:1228-1233.
5. Ames, B.N., L.S. Gold, and W.C. Willett. 1995. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA. 92: 5258-5265.
6. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R.C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:3539-3543.
7. Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T. Bronson, G.R. Dickersin, C.J. Bachurski, E.L. Mark, J.A. Whitsett, and R.C. Mulligan. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science. 264:713-716.
8. Wada, H., Y. Noguchi, M. Marino, A. Dunn, and L. Old. 1997. T cell functions in granulocyte/macrophage colonystimulating factor deficient mice. Proc. Natl. Acad. Sci. USA. 94:12557-12561.
9. Gillessen, S., N. Mach, C. Small, M. Mihm, and G. Dranoff. 2001. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood. 97:922-928.
10. Dalton, D., S. Pitts-Meek, S. Keshav, I. Figari, A. Bradley, and T. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science. 259: 1739-1742.
11. Isenberg, D.A., C. Dudeney, W. Williams, I. Addison, S. Charles, J. Clarke, and A. Todd-Pokropek. 1987. Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann. Rheum. Dis. 46:448-456.
12. Hogarth, M.B., P.J. Norsworthy, P.J. Allen, P.K. Trinder, M. Loos, B.J. Morley, M.J. Walport, and K.A. Davies. 1996. Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice. Clin. Exp. Immunol. 104: 241-246.
13. Taylor, P.R., A. Carugati, V.A. Fadok, H.T. Cook, M. Andrews, M.C. Carroll, J.S. Savill, P.M. Henson, M. Botto, and M.J. Walport. 2000. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192:359-366.
14. Shaw, A.C., W. Swat, L. Davidson, and F.W. Alt. 1999. Induction of Ig light chain gene rearrangement in heavy chaindeficient B cells by activated Ras. Proc. Natl. Acad. Sci. USA. 96:2239-2243.
15. Gao, Y., D. Ferguson, W. Xle, J. Manis, J. Sekiguchi, K. Frank, J. Chaudhuri, J. Horner, R. DePinho, and F. Alt. 2000. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature. 404:897-900.
16. Rosen, A., and L. Casciola-Rosen. 2001. Clearing the way to mechanisms of autoimmunity. Nat. Med. 7:664-665.
17. Shibata, Y., P.Y. Berclaz, Z.C. Chroneos, M. Yoshida, J.A. Whitsett, and B.C. Trapnell. 2001. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity. 15:557-567.
18. Kaplan, D., V. Shankaran, A. Dighe, E. Stockert, M. Aguet, L. Old, and R. Schreiber. 1998. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA. 95:7556-7561.
19. Qin, Z., H.J. Kim, J. Hemme, and T. Blankenstein. 2002. Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction. J. Exp. Med. 195:1479-1490.
20. Street, S.E., E. Cretney, and MJ. Smyth. 2001. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood. 97:192-197.
21. Macy, J., E. Weir, S. Compton, M. Shlomchik, and D. Brownstein. 2000. Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy. Comp. Med. 50:49-55.
22. Balomenos, D., R. Rumold, and A.N. Theofilopoulos. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-1pr mice. J. Clin. Invest. 101:364-371.
23. Knowles, D. 1999. Immunodeficiency-associated lymphoproliferative disorders. Mod. Pathol. 12:200-217.
24. Siegel, R.M., F.K. Chan, H.J. Chun, and M.J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1:469-474.
25. Davidson, W., T. Giese, and T. Fredrickson. 1998. Spontaneous development of plasmacytoid tumors in mice with defective fas-fas ligand interactions. J. Exp. Med. 187:1825-1838.
26. Hoeppner, D.J., M.O. Hengartner, and R. Schnabel. 2001. Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans. Nature. 412:202-206.
27. Reddien, P.W., S. Cameron, and H.R. Horvitz. 2001. Phagocytosis promotes programmed cell death in C. elegans. Nature. 412:198-202.
28. Takahashi, Y., H. Ohta, and T. Takemori. 2001. Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity. 14:181-192.
29. Kuppers, R., U. Klein, M.L. Hansmann, and K. Rajewsky. 1999. Cellular origin of human B-cell lymphomas. N. Engl. J. Med. 341:1520-1529.
30. Street, S.E., J.A. Trapani, D. MacGregor, and M.J. Smyth. 2002. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J. Exp. Med. 196:129-134.